Browsing Tag
Mifepristone
2 posts
Corcept Therapeutics (NASDAQ: CORT) climbs 7% as Lifyorli launch and analyst upgrades drive cortisol re-rating
Corcept turned a stress hormone into an ovarian cancer drug. Lifyorli is launching fast and analysts are chasing, but a premium multiple prices in a lot.
May 28, 2026
Mifepristone under fire: RFK Jr. orders FDA review of abortion pill used in most U.S. procedures
RFK Jr. orders FDA review of mifepristone, the abortion pill used in two-thirds of U.S. abortions. Explore the stakes for access, politics, and regulatory integrity.
September 25, 2025